Cargando…
Clinical Evaluation of Siemens SARS-CoV-2 Total Antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo Metropolitan area
BACKGROUND: We evaluated the efficacy of the Siemens SARS-CoV-2 Total Antibody assay (CV2T) and IgG assay (CV2G) that can detect antibodies against the receptor binding domain of S antigen in patients with COVID-19 in a Tokyo metropolitan area. METHODS: Sensitivity and antibody levels were examined...
Autores principales: | Igawa, Gene, Yamamoto, Takamasa, Baba, Yuna, Shinozuka, Konomi, Yuri, Maiko, Wakita, Mitsuru, Misawa, Shigeki, Miida, Takashi, Ai, Tomohiko, Tabe, Yoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592641/ https://www.ncbi.nlm.nih.gov/pubmed/34805572 http://dx.doi.org/10.1016/j.heliyon.2021.e08393 |
Ejemplares similares
-
Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a University Hospital at Tokyo
por: Igawa, Gene, et al.
Publicado: (2022) -
Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment
por: Takei, Satomi, et al.
Publicado: (2022) -
Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination
por: Takahashi, Toshihiro, et al.
Publicado: (2023) -
Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity
por: Tsuchiya, Koji, et al.
Publicado: (2022) -
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)